Literature DB >> 31317631

GATA-3 in T-cell lymphoproliferative disorders.

Carlos Murga-Zamalloa1, Ryan A Wilcox1.   

Abstract

GATA-3 regulates the differentiation, proliferation, survival, and function of peripheral T cells and their thymic progenitors. Recent findings, reviewed here, not only implicate GATA-3 in the pathogenesis of molecularly, genetically, and clinically distinct T-cell lymphoproliferative disorders, but also have significant diagnostic, prognostic, and therapeutic implications.
© 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  CTCL; GATA-3; PTCL; T-ALL

Year:  2019        PMID： 31317631      PMCID： PMC7184638          DOI： 10.1002/iub.2130

Source DB:  PubMed          Journal:  IUBMB Life        ISSN： 1521-6543            Impact factor:   3.885


  74 in total

Review 1.  Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

Authors:  Javeed Iqbal; Ryan Wilcox; Hina Naushad; Joseph Rohr; Tayla B Heavican; Chao Wang; Alyssa Bouska; Kai Fu; Wing C Chan; Julie M Vose
Journal:  Blood Rev       Date:  2015-08-18       Impact factor: 8.250

2.  Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma.

Authors:  Hongbo Yu; Aliakbar Shahsafaei; David M Dorfman
Journal:  Am J Clin Pathol       Date:  2009-01       Impact factor: 2.493

3.  Mogamulizumab: 2 birds, 1 stone.

Authors:  Ryan A Wilcox
Journal:  Blood       Date:  2015-03-19       Impact factor: 22.113

Review 4.  GATA-3 function in innate and adaptive immunity.

Authors:  Irma Tindemans; Nicolas Serafini; James P Di Santo; Rudi W Hendriks
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

Review 5.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

6.  Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.

Authors:  Manuel Rodriguez-Justo; Ayoma D Attygalle; Phillipa Munson; Giovanna Roncador; Teresa Marafioti; Miguel A Piris
Journal:  Mod Pathol       Date:  2009-03-27       Impact factor: 7.842

7.  Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Authors:  Youn H Kim; Martine Bagot; Lauren Pinter-Brown; Alain H Rook; Pierluigi Porcu; Steven M Horwitz; Sean Whittaker; Yoshiki Tokura; Maarten Vermeer; Pier Luigi Zinzani; Lubomir Sokol; Stephen Morris; Ellen J Kim; Pablo L Ortiz-Romero; Herbert Eradat; Julia Scarisbrick; Athanasios Tsianakas; Craig Elmets; Stephane Dalle; David C Fisher; Ahmad Halwani; Brian Poligone; John Greer; Maria Teresa Fierro; Amit Khot; Alison J Moskowitz; Amy Musiek; Andrei Shustov; Barbara Pro; Larisa J Geskin; Karen Dwyer; Junji Moriya; Mollie Leoni; Jeffrey S Humphrey; Stacie Hudgens; Dmitri O Grebennik; Kensei Tobinai; Madeleine Duvic
Journal:  Lancet Oncol       Date:  2018-08-09       Impact factor: 41.316

Review 8.  Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.

Authors:  Tycel Phillips; Sumana Devata; Ryan A Wilcox
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

9.  DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.

Authors:  L Scourzic; L Couronné; M T Pedersen; V Della Valle; M Diop; E Mylonas; J Calvo; E Mouly; C K Lopez; N Martin; M Fontenay; A Bender; S Guibert; P Dubreuil; P Dessen; N Droin; F Pflumio; M Weber; P Gaulard; K Helin; T Mercher; O A Bernard
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

10.  Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.

Authors:  Owen A O'Connor; Muhit Özcan; Eric D Jacobsen; Josep M Roncero; Judith Trotman; Judit Demeter; Tamás Masszi; Juliana Pereira; Radhakrishnan Ramchandren; Anne Beaven; Dolores Caballero; Steven M Horwitz; Anne Lennard; Mehmet Turgut; Nelson Hamerschlak; Francesco A d'Amore; Francine Foss; Won-Seog Kim; John P Leonard; Pier Luigi Zinzani; Carlos S Chiattone; Eric D Hsi; Lorenz Trümper; Hua Liu; Emily Sheldon-Waniga; Claudio Dansky Ullmann; Karthik Venkatakrishnan; E Jane Leonard; Andrei R Shustov
Journal:  J Clin Oncol       Date:  2019-02-01       Impact factor: 44.544
View more
  2 in total

1.  Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.

Authors:  Yu-Ting Dai; Fan Zhang; Hai Fang; Jian-Feng Li; Gang Lu; Lu Jiang; Bing Chen; Dong-Dong Mao; Yuan-Fang Liu; Jin Wang; Li-Jun Peng; Chong Feng; Hai-Feng Chen; Jun-Xi Mu; Qun-Ling Zhang; Hao Wang; Hany Ariffin; Tan Ah Moy; Jing-Han Wang; Yin-Jun Lou; Su-Ning Chen; Qian Wang; Hong Liu; Zhe Shan; Itaru Matsumura; Yasushi Miyazaki; Takahiko Yasuda; Li-Ping Dou; Xiao-Jing Yan; Jin-Song Yan; Allen Eng-Juh Yeoh; De-Pei Wu; Hitoshi Kiyoi; Fumihiko Hayakawa; Jie Jin; Sheng-Yue Wang; Xiao-Jian Sun; Jian-Qing Mi; Zhu Chen; Jin-Yan Huang; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

Review 2.  Development and Carcinogenesis: Roles of GATA Factors in the Sympathoadrenal and Urogenital Systems.

Authors:  Takashi Moriguchi
Journal:  Biomedicines       Date:  2021-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.